TABLE 1

Guidelines Used for Development of Quality Indicators

Recommendation No.RecommendationRecommendation Level*
2bInhaled bronchodilators should be  continued only if there is a documented  positive clinical response to the trial by  using an objective means of evaluationB, optional use
3Corticosteroid medications should not  be used routinely in the management  of bronchiolitisB, recommendation
5Antibacterial medications should be used  only in children with bronchiolitis who  have specific indications of the  coexistence of a bacterial infectionB, recommendation
  • Source: American Academy of Pediatrics Subcommittee on Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118(4):1776–1781.

  • * Letters correspond to level of evidence as outlined in AAP policy statement (American Academy of Pediatrics Steering Committee on Quality Improvement and Management. Classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114[3]:874–877).